{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-012785","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2025-05-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.599720+00:00","generated_at":"2026-05-20T06:48:02.201561+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Telomir Pharmaceuticals reports Telomir-1 restores vision in AMD animal model","bullets":["Telomir-1 improved central vision response and motion detection in AMD zebrafish model.","Retinal layer regeneration observed: INL, GCL, IPL, OPL thickness increased.","Reactive oxygen species reduced ~50% vs. untreated; 15% mortality in controls vs. 0% in treated.","Results support continued advancement toward IND submission."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-012785","json":"https://secwatch.observer/filing/0001641172-25-012785.json","markdown":"https://secwatch.observer/filing/0001641172-25-012785.md","text":"https://secwatch.observer/filing/0001641172-25-012785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225012785/0001641172-25-012785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000164117225012785/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T06:48:02.201561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}